{"id":"https://openalex.org/W3144023344","doi":"https://doi.org/10.1002/cpdd.923","title":"Hemodialysis Clearance of Enarodustat (JTZ\u2010951), an Oral Erythropoiesis Stimulating Agent, in Patients with End\u2010Stage Renal Disease","display_name":"Hemodialysis Clearance of Enarodustat (JTZ\u2010951), an Oral Erythropoiesis Stimulating Agent, in Patients with End\u2010Stage Renal Disease","publication_year":2021,"publication_date":"2021-03-31","ids":{"openalex":"https://openalex.org/W3144023344","doi":"https://doi.org/10.1002/cpdd.923","mag":"3144023344","pmid":"https://pubmed.ncbi.nlm.nih.gov/33788422"},"language":"en","primary_location":{"id":"doi:10.1002/cpdd.923","doi":"https://doi.org/10.1002/cpdd.923","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpdd.923","pdf_url":null,"source":{"id":"https://openalex.org/S2764863641","display_name":"Clinical Pharmacology in Drug Development","issn_l":"2160-763X","issn":["2160-763X","2160-7648"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology in Drug Development","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063284241","display_name":"Sudhakar M. Pai","orcid":"https://orcid.org/0000-0001-8091-546X","observed_orcids":["https://orcid.org/0000-0001-8091-546X"]},"institutions":[{"id":"https://openalex.org/I4405267189","display_name":"Akros Pharma Inc. (United States)","ror":"https://ror.org/01k528p38","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267189"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sudhakar M. Pai","raw_affiliation_strings":["Clinical Pharmacology, Akros Pharma, Inc., Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Akros Pharma, Inc., Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4405267189"]}]},{"author_position":"last","author":{"id":null,"display_name":"Hiroyuki Yamada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108598","display_name":"Japan Tobacco (Japan)","ror":"https://ror.org/01xdq1k91","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210108598"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyuki Yamada","raw_affiliation_strings":["Clinical Pharmacology, Pharmaceutical Division, Japan Tobacco Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Pharmaceutical Division, Japan Tobacco Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210108598"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5063284241"],"corresponding_institution_ids":["https://openalex.org/I4405267189"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":0.6474,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.65795577,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"10","issue":"5","first_page":"463","last_page":"470"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.019300000742077827,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.9829999804496765},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8429999947547913},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.8700000047683716},{"id":"https://openalex.org/keywords/unbound-drug-concentration","display_name":"unbound drug concentration","score":0.8220000267028809},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.4729999899864197},{"id":"https://openalex.org/keywords/anemia-of-chronic-kidney-disease","display_name":"anemia of chronic kidney disease","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.8371124267578125},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7458762526512146},{"id":"https://openalex.org/C2779978075","wikidata":"https://www.wikidata.org/wiki/Q202301","display_name":"Dialysis","level":2,"score":0.6717324256896973},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6248968243598938},{"id":"https://openalex.org/C3019040382","wikidata":"https://www.wikidata.org/wiki/Q476921","display_name":"End stage renal disease","level":3,"score":0.5800551772117615},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.4618147611618042},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.4482106864452362},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4214664697647095},{"id":"https://openalex.org/C89838059","wikidata":"https://www.wikidata.org/wiki/Q623738","display_name":"Coefficient of variation","level":2,"score":0.41341379284858704},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.41243934631347656},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4067176878452301},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3859924077987671},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.27950865030288696},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.21810013055801392}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006435","descriptor_name":"Renal Dialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034442","descriptor_name":"N-substituted Glycines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/cpdd.923","doi":"https://doi.org/10.1002/cpdd.923","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpdd.923","pdf_url":null,"source":{"id":"https://openalex.org/S2764863641","display_name":"Clinical Pharmacology in Drug Development","issn_l":"2160-763X","issn":["2160-763X","2160-7648"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology in Drug Development","raw_type":"journal-article"},{"id":"pmid:33788422","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33788422","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology in drug development","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W154339798","https://openalex.org/W190717980","https://openalex.org/W2009192569","https://openalex.org/W2035855731","https://openalex.org/W2063610505","https://openalex.org/W2073579626","https://openalex.org/W2086913408","https://openalex.org/W2128821627","https://openalex.org/W2144625075","https://openalex.org/W2152233370","https://openalex.org/W2163768678","https://openalex.org/W2257941018","https://openalex.org/W2584676146","https://openalex.org/W2768888006","https://openalex.org/W2914891827","https://openalex.org/W2946106947","https://openalex.org/W2957217375","https://openalex.org/W2998124187","https://openalex.org/W6677214971","https://openalex.org/W7073682614"],"related_works":["https://openalex.org/W4377093057","https://openalex.org/W2998124187","https://openalex.org/W2040141167","https://openalex.org/W2084376430","https://openalex.org/W1985779503","https://openalex.org/W2008826908","https://openalex.org/W4294556237","https://openalex.org/W1982740805","https://openalex.org/W2052233064","https://openalex.org/W2032368340"],"abstract_inverted_index":{"The":[0],"dialysis":[1,270],"clearance":[2,41,229],"of":[3,51,96,98,244,253,260,269],"enarodustat":[4,48,62,182,188,264],"(JTZ-951)":[5],"was":[6,23,42,117,131,167,217,232,250],"determined":[7],"in":[8,55,248,278],"patients":[9,279],"(N":[10],"=":[11],"6)":[12],"with":[13,33,81,170,193,201,255,280],"end-stage":[14,281],"renal":[15,282],"disease":[16,283],"on":[17,36,44,107,124,134,173,221,284],"hemodialysis.":[18,285],"Enarodustat":[19],"(5":[20],"mg":[21],"PO)":[22],"administered":[24,52,245,267],"before":[25],"(day":[26,31],"1)":[27],"and":[28,46,59,64,66,101,110,113,120,177,180,241,272],"after":[29],"hemodialysis":[30],"8)":[32],"pharmacokinetic":[34],"assessments":[35],"the":[37,86,125,145,155,174,208,242],"2":[38,126,175],"occasions.":[39,127],"Dialysis":[40,228],"based":[43],"plasma":[45,61,69,87,156,209,237],"dialysate":[47,249],"concentrations.":[49],"Fraction":[50],"dose":[53,246,273],"recovered":[54,247],"dialysate,":[56],"total":[57,65,79,151,178],"predialyzer":[58],"postdialyzer":[60,181],"concentrations,":[63],"unbound":[67,187,205],"venous":[68],"concentrations":[70,80,183,189],"were":[71,184],"determined.":[72],"Hemodialysis":[73],"did":[74,147],"not":[75,148,276],"significantly":[76,149],"affect":[77,150],"overall":[78],"similar":[82,171],"mean":[83,114],"area":[84,206],"under":[85,154,207],"concentration-time":[88,157,210],"curve":[89,158,211],"from":[90,159,212],"time":[91,160,213],"0":[92,161,214],"to":[93,138,162,199,215,225,235],"infinity":[94,216],"(coefficient":[95,259],"variation)":[97],"3350":[99],"(26.4%)":[100],"3640":[102],"(20.9%)":[103],"ng":[104],"\u00b7":[105],"h/mL":[106],"days":[108],"1":[109,136,223],"8,":[111],"respectively,":[112],"terminal":[115],"half-life":[116],"9.35":[118],"(11.9%)":[119],"9.96":[121],"(18.7%)":[122],"hours":[123],"Mean":[128,204],"maximum":[129],"concentration":[130],"somewhat":[132],"lower":[133,219],"day":[135,139,222,226],"compared":[137,224],"8":[140],"(404":[141],"vs":[142],"559":[143],"ng/mL);":[144],"difference":[146],"exposure":[152],"(area":[153],"infinity).":[163],"Plasma":[164,186],"protein":[165],"binding":[166,172],"high":[168],"(>99%)":[169],"occasions,":[176],"pre-":[179],"similar.":[185],"decreased":[190],"during":[191],"dialysis,":[192],"a":[194],"postdialysis":[195],"rebound":[196],"presumably":[197],"due":[198],"re-equilibration":[200],"peripheral":[202],"tissues.":[203],"marginally":[218],"(\u223c22%)":[220],"8.":[227],"(0.415":[230],"L/h)":[231],"insignificant":[233],"relative":[234],"dialyzer":[236],"flow":[238],"(\u223c20":[239],"L/h),":[240],"fraction":[243],"small":[251],"(6.74%":[252],"dose)":[254],"low":[256],"intersubject":[257],"variability":[258],"variation,":[261],"14.7%).":[262],"Thus,":[263],"can":[265],"be":[266],"regardless":[268],"schedule,":[271],"supplementation":[274],"is":[275],"required":[277]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-04-13T00:00:00"}